Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation
Molecular Biology Reports · 2025
DOI: 10.1007/s11033-025-11056-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Biology Reports, 2025. Verfasst von Safin Hussein und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. safin.hussein@uor…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Vitamin D. Die Arbeit nennt 44 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 1 diabetes mellitus (T1DM) is an autoimmune disease characterized by the destruction of pancreatic beta cells. Vitamin D is known to have immunomodulatory effects that may influence T1DM; however, its impact on immune gene expression in T1DM patients remains unclear. This study aimed to explore the effects of vitamin D on immunomodulatory gene expression in T1DM patients through bioinformatics analysis and qRT‒PCR validation. Two microarray datasets (GSE55098 and GSE50012) were analyzed to identify differentially expressed genes (DEGs) in T1DM and vitamin D-treated samples. Enrichment analysis and protein‒protein interaction (PPI) network analysis were used to identify key immune genes. qRT‒PCR was then performed on peripheral blood mononuclear cells (PBMCs) from T1DM patients and healthy controls. The analysis revealed 100 DEGs shared between the two datasets, with 58 showing opposite regulation. Six key immunomodulatory genes (CD226, CD40, RSAD2, OAS3, PTGS2, and LAMP3) were identified. qRT‒PCR confirmed the significant dysregulation of these genes in T1DM patients. Vitamin D treatment led to the downregulation of most genes, except for LAMP3, whose expression remained unchanged. Vitamin D modulates the expression of key immune genes in T1DM, suggesting its potential as an adjunctive therapy. Future studies should validate these findings with larger cohorts and explore the long-term effects of vitamin D on immune regulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran. safin.hussein@uor.edu.krd.
- Department of Biology, College of Science, University of Raparin, Ranya, Kurdistan Region, Iraq. safin.hussein@uor.edu.krd.
- Department of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
- Department of Medical and Translational Biology, Umeå University, Ume, Sweden.
- Cancer Prevention Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Biology, College of Science, University of Raparin, Ranya, Kurdistan Region, Iraq.
Zitieren
APA
Hussein, S., Mahmoudi-Aznaveh, A., Nekoeian, S., Qurbani, K., Panji, M., Zakeri, P., Bandarian, F., Motevaseli, E., & Azizi, Z. (2025). Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation. Molecular Biology Reports. https://doi.org/10.1007/s11033-025-11056-3
Vancouver
Hussein S, Mahmoudi-Aznaveh A, Nekoeian S, Qurbani K, Panji M, Zakeri P, et al. Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation. Molecular Biology Reports. 2025. doi:10.1007/s11033-025-11056-3
BibTeX
@article{Hussein2025,
author = {Hussein, Safin and Mahmoudi-Aznaveh, Azam and Nekoeian, Shahram and Qurbani, Karzan and Panji, Mohammad and Zakeri, Pooya and Bandarian, Fatemeh and Motevaseli, Elahe and Azizi, Zahra},
title = {Analysis of vitamin D-induced immunomodulatory gene expression changes in type 1 diabetes: from computational prediction to experimental validation},
journal = {Molecular Biology Reports},
year = {2025},
doi = {10.1007/s11033-025-11056-3}
}
EUVIMED